$100.00
A triple agonist research peptide targeting GIP, GLP-1, and glucagon receptors. Manufactured for precision and purity in laboratory research — not for human consumption.
16 in stock
Retatrutide is an advanced synthetic peptide designed to activate three key metabolic receptors — glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. This multi-target engagement offers a unique research platform for studying complex metabolic regulation, energy expenditure, glycemic balance, and body composition in controlled preclinical models.
The different vial size is ideal for long-term experimental protocols, multiple concurrent research streams, or high-volume laboratory programs where reliability of supply and batch consistency are essential.
Key Research Notes:
Triple receptor activation may provide synergistic effects in metabolic pathway studies
Manufactured under stringent quality controls to ensure high purity and reproducibility
Suitable for extended or multi-phase research protocols
Disclaimer:
For research use only. Not for human consumption, medical, or veterinary use.
| Mg | 10, 30 |
|---|
Reviews
There are no reviews yet.